Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02471716
Title Study of FPA008 in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Five Prime Therapeutics, Inc.
Indications

tenosynovial giant cell tumor

Therapies

Cabiralizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.